Memorial Sloan Kettering received a landmark gift of $100 million to undertake a unique and intensive endeavor to transform cancer care through genomic analysis of patient-derived tumors. President and CEO Craig Thompson was interviewed.
Pediatric oncologist Rachel Kobos and occupational therapist Christine Connelly were interviewed about Memorial Sloan Kettering’s pediatric gym and rehab facility. A young Memorial Sloan Kettering patient was also featured.
Melanoma and Immunotherapeutics Service Chief Jedd Wolchok shared his thoughts on updated research that shows that the effects of drug-based immunotherapy can sometimes last for years in patients who were treated for advanced melanoma.
Medical oncologist Michael Morris was interviewed about a new study that found that men given chemotherapy early in their treatment for advanced prostate cancer lived longer than those who did not get early chemotherapy.
Physician-in-Chief José Baselga was interviewed about Memorial Sloan Kettering’s collaboration with Quest Diagnostics to screen patients’ cancer genes and help doctors choose the best treatments. Memorial Sloan Kettering’s Marc Ladanyi, David Solit and Charles Sawyers were also interviewed.